24/7 Market News Snapshot 28 February, 2025 – Rapid Micro Biosystems, Inc. Class A Common Stock (NASDAQ:RPID)

February 28, 2025

DENVER, Colo., 28 February, 2025 (247marketnews.com) – (NASDAQ:RPID) are discussed in this article.
Rapid Micro Biosystems, Inc. is witnessing a notable upswing in its stock performance, with shares currently trading at $3.604, reflecting an impressive 8.88% increase from the previous closing value of $3.310 in pre-market trading. This surge coincides with a substantial trading volume of 4.35 million shares, signaling strong investor enthusiasm and possible upward momentum. Analysts are closely observing key resistance levels above $3.60, assessing whether this bullish trend will persist, while support at $3.30 is essential for maintaining positive market sentiment in the short run.

In addition to its favorable stock performance, Rapid Micro Biosystems has reported record financial results for the fourth quarter and full year ending December 31, 2024. The company achieved total revenues of $8.2 million for Q4 2024, marking a significant 30% rise compared to Q4 2023. For the entire fiscal year 2024, total revenues reached $28.1 million, demonstrating a strong year-over-year growth of 25%. Notably, recurring revenue in Q4 saw a 27% increase, reflecting the growing adoption of its innovative automation solutions for microbial quality control.

Gross margins have also witnessed substantial improvement, with Q4 margins rising by 15 percentage points to 12%, and full-year margins showing a similar increase of 24 percentage points compared to the previous year. CEO Robert Spignesi acknowledged the strong sales and gross margin performance as a testament to the company’s strategic focus on innovation.

A significant milestone is the recent global Distribution and Collaboration Agreement with MilliporeSigma, aimed at enhancing market access and facilitating technological advancements. This partnership is anticipated to bolster Rapid Micro Biosystems’ positioning in the market, further establishing its Growth Direct system as the benchmark in microbial quality control automation. With 21 system placements and 16 customer validations achieved, the company is optimistic about its strategic objectives for 2025, aiming for a revenue target of at least $32 million and continued shareholder value enhancement through innovation and strategic partnerships.

Related news for (RPID)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.